COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 13th, 2021 • Liquidia Corp • Pharmaceutical preparations • New York
COMMON STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of April 12, 2021, by and among Liquidia Corporation, a Delaware corporation, with headquarters located at 419 Davis Drive, Suite 100, Morrisville, NC 27560 (the “Company”) and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 13th, 2021 • Liquidia Corp • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of April 12, 2021, by and among Liquidia Corporation, a Delaware corporation (the “Company”) and the purchasers identified on Schedule A hereto (each, a “Purchaser” and collectively, the “Purchasers”) and such other Persons, if any, from time to time, that become a party hereto as holders of Registrable Securities (as defined below).
STANDSTILL AGREEMENTStandstill Agreement • April 13th, 2021 • Liquidia Corp • Pharmaceutical preparations • Delaware
This Standstill Agreement, dated as of April 13, 2021 (this “Agreement”), is by and between Liquidia Corporation, a Delaware corporation (the “Company”), and Caligan Partners CV IV LP (the “New Company Investor”).
